» Articles » PMID: 36397119

Diagnostic Delay in Rare Diseases: Data from the Spanish Rare Diseases Patient Registry

Overview
Publisher Biomed Central
Specialty General Medicine
Date 2022 Nov 18
PMID 36397119
Authors
Affiliations
Soon will be listed here.
Abstract

Background: According to the International Rare Diseases Research Consortium (IRDiRC), a known rare disease (RD) should be diagnosable within a year. This study sought: firstly, to ascertain how long it takes to obtain the diagnosis of a RD in Spain, along with its associated time trend; and secondly, to identify and measure diagnostic delay (defined by the IRDiRC as any period exceeding a year) by reference to the characteristics of RDs and the persons affected by them.

Methods: Using data sourced from the Spanish Rare Diseases Patient Registry, we performed a descriptive analysis of the time elapsed between symptom onset and diagnosis of each RD, by sex, age and date of symptom onset, and type of RD. We analysed the time trend across the period 1960-2021 and possible change points, using a Joinpoint regression model and assuming a Poisson distribution. The multivariate analysis was completed with backward stepwise logistic regression.

Results: Detailed information was obtained on 3304 persons with RDs: 56.4% had experienced delay in diagnosis of their RDs, with the mean time taken being 6.18 years (median = 2; IQR 0.2-7.5). Both the percentage of patients with diagnostic delay and the average time to diagnosis underwent a significant reduction across the study period (p < 0.001). There was a higher percentage of diagnostic delays: in women (OR 1.25; 95% CI 1.07-1.45); in cases with symptom onset at age 30-44 years (OR 1.48; 95% CI 1.19-1.84): and when analysed by type of RD, in mental and behavioural disorders (OR 4.21; 95% CI 2.26-7.85), followed by RDs of the nervous system (OR 1.39; 95% CI 1.02-1.88).

Conclusions: This is the first study to quantify time to diagnosis of RDs in Spain, based on data from a national registry open to any RD. Since over half of all persons affected by RDs experience delay in diagnosis, new studies are needed to ascertain the factors associated with this delay and the implications this has on the lives of patients and their families.

Citing Articles

A global survey about undiagnosed rare diseases: perspectives, challenges, and solutions.

Baldovino S, Sciascia S, Carta C, Salvatore M, Cellai L, Ferrari G Front Public Health. 2025; 13:1510818.

PMID: 40078755 PMC: 11897027. DOI: 10.3389/fpubh.2025.1510818.


Characterization of patients treated at a rare disease referral service: a descriptive study, 2016-2021.

Carvalho E, Hopker R, Pedroso G, Almeida L, Pacher J, Antonio A Epidemiol Serv Saude. 2025; 33():e20240204.

PMID: 39776132 PMC: 11660309. DOI: 10.1590/S2237-96222024v33e20240204.en.


as a Model for Human Disease: Insights into Rare and Ultra-Rare Diseases.

Casas-Tinto S Insects. 2024; 15(11).

PMID: 39590469 PMC: 11594678. DOI: 10.3390/insects15110870.


Would Artificial Intelligence Improve the Quality of Care of Patients With Rare Diseases?.

Abukhadijah H, Nashwan A Glob J Qual Saf Healthc. 2024; 7(4):149-150.

PMID: 39534241 PMC: 11554393. DOI: 10.36401/JQSH-24-X3.


Rising to the Challenge of Rare Diagnoses.

Venus K, Kwan J, Frost D J Gen Intern Med. 2024; .

PMID: 39485586 DOI: 10.1007/s11606-024-09086-x.


References
1.
Palese F, Sartori A, Logroscino G, Pisa F . Predictors of diagnostic delay in amyotrophic lateral sclerosis: a cohort study based on administrative and electronic medical records data. Amyotroph Lateral Scler Frontotemporal Degener. 2019; 20(3-4):176-185. DOI: 10.1080/21678421.2018.1550517. View

2.
Hogler W, Langman C, da Silva H, Fang S, Linglart A, Ozono K . Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry. BMC Musculoskelet Disord. 2019; 20(1):80. PMC: 6376686. DOI: 10.1186/s12891-019-2420-8. View

3.
Bloss S, Klemann C, Rother A, Mehmecke S, Schumacher U, Mucke U . Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey. PLoS One. 2017; 12(2):e0172532. PMC: 5325301. DOI: 10.1371/journal.pone.0172532. View

4.
Boettcher J, Boettcher M, Wiegand-Grefe S, Zapf H . Being the Pillar for Children with Rare Diseases-A Systematic Review on Parental Quality of Life. Int J Environ Res Public Health. 2021; 18(9). PMC: 8125857. DOI: 10.3390/ijerph18094993. View

5.
Benito-Lozano J, Arias-Merino G, Gomez-Martinez M, Ancochea-Diaz A, Aparicio-Garcia A, Posada de la Paz M . Diagnostic Process in Rare Diseases: Determinants Associated with Diagnostic Delay. Int J Environ Res Public Health. 2022; 19(11). PMC: 9180264. DOI: 10.3390/ijerph19116456. View